期刊文献+

他克莫司软膏联合乌龙散治疗白癜风的疗效及对血清IL-18和IFN-γ的影响 被引量:7

下载PDF
导出
摘要 目的观察他克莫司软膏联合乌龙散治疗白癜风的疗效及对患者血清IL-18和IFN-γ的影响。方法将72例白癜风患者随机分为治疗组(36例)和对照组(36例),2组都外搽他克莫司软膏,治疗组再口服乌龙散,比较2组治疗前后血清IL-18和IFN-γ水平的变化及临床效果。结果治疗12周后,治疗组血清中IL-18和IFN-γ水平显著低于治疗前(P均<0.05),对照组治疗前后上述指标比较差异均无统计学意义(P均>0.05);治疗组显效率、总有效率均显著高于对照组(P均<0.05),起效时间明显短于对照组(P<0.05)。结论他克莫司软膏可影响白癜风患者血清中IL-18和IFN-γ水平,联合用药的临床效果优于单用乌龙散。
作者 于越 冯玉康
出处 《现代中西医结合杂志》 CAS 2016年第3期293-295,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献9

  • 1Grimes PE,Soriano T, Dytoc MT. Topical tacrolimus for repigmenta- tion of vitiligo[ J]. J Am Acad Dermatol,2002,47 (5) :789 - 791.
  • 2伍金妹,侯宜金.他克莫司软膏治疗白癜风的随机对照开放研究[J].中国医药指南,2011,9(18):25-26. 被引量:4
  • 3白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 4查方旭.胸腺肽和乌龙散联合治疗白癜风的临床疗效观察[J].大众健康(理论版),2012(10):139-140. 被引量:2
  • 5Lan CC, Chert CS, Chiou MH, et al. FKS06 Promotesmelanncyte and melanoblast growth and creates a favourable millionfor cell mi gration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in pients with vitiligo [ J]. Br J Dermatol,2005,153 ( 3 ) :498.
  • 6Silverg NB, Lin P, Travis L, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children : A review of 57 cases [ J ]. J Am Acad Dermatol,2004,51 ( 5 ) :760 - 766.
  • 7田波,何立,赵洪波,彭才智,周赛南,王雪.白癜风患者血浆IL-18表达水平和免疫功能的研究[J].中国麻风皮肤病杂志,2013,29(10):678-679. 被引量:3
  • 8Ushio S,Namba M, Okura T,et al. Cloning of the cDNA for humanIFN - inducing factor, expression in Escherichia eoli,and studies on the biologic activities of the protein [ J]. J Immunol, 1996,156 ( 11 ) :4274 -4279.
  • 9Harris JE,Harris TH,Wolfgang W,et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN - ',/for autore- active CD8 T - cell accumulation in the skin [ J]. The Journal of investigative dermatology ,2012,132 (7) : 1869 - 1876.

二级参考文献12

  • 1王娟,马慧群.白癜风的治疗进展[J].中国医学文摘(皮肤科学),2010,27(3):149-153. 被引量:14
  • 2白癜风临床分型及疗效标准(2003年修订稿)[J].中华皮肤科杂志,2004,37(7):440-440. 被引量:801
  • 3Pawlik A, Kaminski M, Kusnierczyk P, et al. Interleukin- 18 promoter polymor- phism in patients with atopic asthma. Tis- sue Antigens, 2007,70(4) :314-318.
  • 4Joshi VD, Kalvakolanu DV, Hasday JD, et al. IL-18 levels and the outcome of in- nate immune response to lipopolysaccha- ride: importance of a positive feedback loop with caspase- 1 in IL- 18 expression. J Immunol, 2009,169(5) :2536-2544.
  • 5Andrews DM, Chow MT, Ma Y, et al. Homeostatic defects in interleukin 18-de- ficient mice contribute to protection against the lethal effects of endotoxin. Immunol Cell Biol, 2011,89 (6) : 739-746.
  • 6Krakowiak A, Walusiak J, Krawczyk P, et al. IL-18 levels in nasal lavage after in- halatory challenge test with f~our in hake~s diagnosed with occupational asthma. Int J Occup Med Environ Heahh,2008,21 (2) : 165-172.
  • 7Khripko OP, Sennikova NS, Lopatnikova JA, et al. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononu- clear cells from healthy donors. Mediators Inflamm, 2008,309721.
  • 8Attili VR, Attili SK. Lichenoid inflamma- tion in vitiligo-a clinical and histopatho- logic review of 210 cases. Int J Dermatol, 2008,47 : 663- 669.
  • 9Boissy RE. Vitiligo. In: Picardo M; Taieb A, editors. Occupational vitiligo. Heidel- berg : Springer Verlag, 2010.175-180.
  • 10Ezzedine K, Diallo A, L6autO-Labraze C, et al. Multivariate analysis of factors asso- ciated with early-onset segmental and non- segmental vitiligo: a prospective observa- tional study of 213 patients. Br J Derma- tol,2011,165 (1) :44-49.

共引文献806

同被引文献84

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部